Description
NMN (u03b2-Nicotinamide Mononucleotide) 500mg delivers 500mg of u03b2-NMN in one delayed-release capsule, taken once daily. It is a single-active formulation u2014 u03b2-NMN, hydroxypropyl methylcellulose, and the HPMC delayed-release shell, and nothing else. Camden makes no health claim for NMN, because none is authorised in Great Britain. Two things are worth knowing before choosing it. NMN is a novel food that is not yet authorised in GB; the FSA determination has not concluded, and products linked to an in-process application may remain on the market under transitional arrangements meanwhile. And EFSA’s 2026 opinion on u03b2-NMN judged up to 300mg a day safe for adults, excluding pregnancy and breastfeeding, and did not assess higher intakes u2014 this product supplies 500mg, above the level assessed, at the only dose a one-capsule format allows. Camden states that rather than leaving it to be found.
Per 1-capsule serving
- NMN (u03b2-Nicotinamide Mononucleotide) u2014 500mg
Key features
- Single active, clean carrier u2014 u03b2-NMN, HPMC and the capsule shell; no fillers, bulking agents, sweeteners or anti-caking agents
- 500mg u03b2-NMN per capsule, one capsule daily u2014 60 capsules is a 60-day supply
- Delayed-release HPMC capsule shell u2014 the format specified by the manufacturer; no absorption or release-performance claim is made for it
- Not suitable during pregnancy or breastfeeding, and not recommended under 18 without medical advice
- Suitable for vegetarians and vegans
- No authorised GB health claim exists for NMN u2014 this is sold on its formulation and on Camden’s published account of the evidence, not on a claim
How to take: Adults, take 1 (one) capsule per day with water. It can be taken with or without food. Do not exceed the recommended daily serving.
Manufactured to the GMP code of practice.
